Ganaxolone (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Ganaxolone" in English language version.

refsWebsite

Global rank English rank

4^th place

1^st place

447^th place

338^th place

2^nd place

68^th place

117^th place

11^th place

8^th place

1,182^nd place

725^th place

doi.org

Kaminski RM, Livingood MR, Rogawski MA (July 2004). "Allopregnanolone analogs that positively modulate GABA receptors protect against partial seizures induced by 6-Hz electrical stimulation in mice". Epilepsia. 45 (7): 864–867. doi:10.1111/j.0013-9580.2004.04504.x. PMID 15230714. S2CID 21974013.
Reddy DS, Rogawski MA (May 2010). "Ganaxolone suppression of behavioral and electrographic seizures in the mouse amygdala kindling model". Epilepsy Research. 89 (2–3): 254–260. doi:10.1016/j.eplepsyres.2010.01.009. PMC 2854307. PMID 20172694.
Thomas P, Pang Y (24 June 2020). "Anti-apoptotic Actions of Allopregnanolone and Ganaxolone Mediated Through Membrane Progesterone Receptors (PAQRs) in Neuronal Cells". Frontiers in Endocrinology. 11 (417): 417. doi:10.3389/fendo.2020.00417. PMC 7331777. PMID 32670200.

"Ztalmy EPAR". European Medicines Agency. 31 July 2023. Archived from the original on 25 August 2023. Retrieved 25 August 2023.

"Drug Trials Snapshots: Ztalmy". U.S. Food and Drug Administration. 18 March 2022. Retrieved 9 October 2023. This article incorporates text from this source, which is in the public domain.
"Advancing Health Through Innovation: New Drug Therapy Approvals 2022". U.S. Food and Drug Administration (FDA). 10 January 2023. Archived from the original on 21 January 2023. Retrieved 22 January 2023. This article incorporates text from this source, which is in the public domain.
New Drug Therapy Approvals 2022 (PDF). U.S. Food and Drug Administration (FDA) (Report). January 2024. Archived from the original on 14 January 2024. Retrieved 14 January 2024. This article incorporates text from this source, which is in the public domain.

Carter RB, Wood PL, Wieland S, Hawkinson JE, Belelli D, Lambert JJ, et al. (March 1997). "Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one), a selective, high-affinity, steroid modulator of the gamma-aminobutyric acid(A) receptor". The Journal of Pharmacology and Experimental Therapeutics. 280 (3): 1284–1295. PMID 9067315.
Kaminski RM, Livingood MR, Rogawski MA (July 2004). "Allopregnanolone analogs that positively modulate GABA receptors protect against partial seizures induced by 6-Hz electrical stimulation in mice". Epilepsia. 45 (7): 864–867. doi:10.1111/j.0013-9580.2004.04504.x. PMID 15230714. S2CID 21974013.
Reddy DS, Rogawski MA (May 2010). "Ganaxolone suppression of behavioral and electrographic seizures in the mouse amygdala kindling model". Epilepsy Research. 89 (2–3): 254–260. doi:10.1016/j.eplepsyres.2010.01.009. PMC 2854307. PMID 20172694.
Thomas P, Pang Y (24 June 2020). "Anti-apoptotic Actions of Allopregnanolone and Ganaxolone Mediated Through Membrane Progesterone Receptors (PAQRs) in Neuronal Cells". Frontiers in Endocrinology. 11 (417): 417. doi:10.3389/fendo.2020.00417. PMC 7331777. PMID 32670200.

"Ztalmy- ganaxolone suspension". DailyMed. 15 November 2022. Archived from the original on 21 January 2023. Retrieved 21 January 2023.

"PubChem compound summary for ganaxolone". PubChem databade. National Library of Medicine (National Center for Biotechnology Information). Archived from the original on 10 December 2022. Retrieved 6 August 2022.

US20190160078A1, Masuoka, Lorianne K. & Lappalainen, Jaakko, "Ganaxolone for use in treating genetic epileptic disorders", issued 2019-05-30

Kaminski RM, Livingood MR, Rogawski MA (July 2004). "Allopregnanolone analogs that positively modulate GABA receptors protect against partial seizures induced by 6-Hz electrical stimulation in mice". Epilepsia. 45 (7): 864–867. doi:10.1111/j.0013-9580.2004.04504.x. PMID 15230714. S2CID 21974013.

"Ztalmy- ganaxolone suspension". DailyMed. 15 November 2022. Archived from the original on 21 January 2023. Retrieved 21 January 2023.
"Ztalmy EPAR". European Medicines Agency. 31 July 2023. Archived from the original on 25 August 2023. Retrieved 25 August 2023.
"Advancing Health Through Innovation: New Drug Therapy Approvals 2022". U.S. Food and Drug Administration (FDA). 10 January 2023. Archived from the original on 21 January 2023. Retrieved 22 January 2023. This article incorporates text from this source, which is in the public domain.
New Drug Therapy Approvals 2022 (PDF). U.S. Food and Drug Administration (FDA) (Report). January 2024. Archived from the original on 14 January 2024. Retrieved 14 January 2024. This article incorporates text from this source, which is in the public domain.
"PubChem compound summary for ganaxolone". PubChem databade. National Library of Medicine (National Center for Biotechnology Information). Archived from the original on 10 December 2022. Retrieved 6 August 2022.